HHS Proposes New OPO Oversight Reforms: What Organ Procurement Professionals Should Know

If you work in organ procurement, you probably saw the headlines this week and felt your stomach drop a little. On October 20, 2026, the U.S. Department of Health and Human Services (HHS) released the Kidney Care National Plan, and a good part of it is about OPOs.

I read the plan, the press release, and the fact sheet so you don't have to piece it together from social media. Here is the most important thing up front: these are federal priorities and proposed actions, not new rules you have to follow today. Most of the OPO items are written as things HHS "will consider" or "should consider."

Let's walk through what's actually in it, what's already happening, and what it could mean for those of us on the floor at 3 a.m. with a donor family.

1. What Is the Kidney Care National Plan?

The plan is a department-wide HHS strategy for kidney care. According to the HHS press release, it centers on three priorities:

  • Prevent kidney failure: detect kidney disease earlier and intervene sooner.
  • Improve dialysis care and expand patient choice: more competition, fewer barriers for new providers, and more home-based care.
  • Reform transplantation: strengthen safety, transparency, and accountability across the transplant system while expanding access to living and deceased donor transplantation.

So while it has "kidney" in the name, the third priority reaches the whole organ procurement and transplant system. It builds on work already underway, including the OPTN Modernization effort HRSA launched in 2023.

2. Why OPOs Are a Focus

HHS lays out its reasoning plainly, so I'll report it the same way. In the plan's words, OPOs "operate as regional monopolies across 54 Donation Service Areas," and "Medicare reimburses OPOs on a cost basis, meaning there is no financial pressure to operate efficiently or improve performance."

A little context for newer coordinators:

  • Each OPO is federally designated to serve a specific Donation Service Area (DSA).
  • Medicare reimburses qualifying organ acquisition costs.
  • CMS finalized OPO performance standards in 2020, based on organs procured and transplanted.
  • The plan notes that no OPO had been decertified for performance reasons until September 2025.

That is HHS's stated rationale. Many in our field would describe the picture differently, and you'll see some of that below. The point here is to understand what the government says it is trying to fix.

3. A Possible Fast Track for New OPOs

This is one of the more consequential ideas. The full plan says HHS "could consider fast tracking efforts to implement a certification process for new OPOs to enable more competition." The fact sheet lists it among actions HHS "will consider."

Why does it matter? Today, becoming an OPO isn't like opening a new clinic down the street. If entry became easier, it could eventually mean:

  • More organizations competing for DSAs.
  • Bigger consequences for OPOs that underperform.
  • New organizations taking over areas served for years by established OPOs.
  • More mergers, partnerships, or restructuring.

Important caveat: HHS has not announced a new certification process. The plan says it could consider one. Those are very different things.

4. A Proposed Organ Donation Corruption and Safety Task Force

This is the part that made headlines. The plan says HHS "should consider creating an Organ Donation Corruption and Safety Task Force, in coordination with relevant law enforcement agencies and state and federal partners, to ensure timely investigation of safety and fraud concerns." The fact sheet also names congressional partners.

It didn't come out of nowhere. On August 5, 2026, HHS announced it had begun decertifying Network for Hope, the OPO serving Kentucky and parts of Indiana, Ohio, and West Virginia. HHS said multiple federal reviews by CMS and HRSA found persistent patient safety failures. CMS's public notice set the termination date for November 3, 2026. Network for Hope has said it is appealing and continues to operate during the appeal.

The plan also calls for better patient safety oversight inside OPOs, including monitoring the requirement to have dedicated Patient Safety Officers.

5. More Scrutiny of Finances and Billing

The plan says HHS should consider ways to "eliminate potential fraud by ensuring OPOs are appropriately billing organ acquisition costs and adhering to their obligations as non-profit entities." It also mentions reviewing payment processes so incentives promote patient safety.

I want to be careful here. This is a proposal for more oversight. It is not a finding that OPOs in general are billing improperly. For most of us, it simply means good documentation and clean cost reporting will matter even more.

6. Performance Is About More Than Organ Counts

The 2020 standards measure how many potential donors become donors and how many organs are transplanted. Those numbers matter. Every one is a person on the list.

But anyone who has worked a case knows the number doesn't show the whole story: the family conversation, the donor management overnight, the safety checks, and the respect shown to the donor. The plan itself puts safety right next to performance, which tells you oversight is moving beyond counts alone.

7. What an OPO Can't Control

Some outcomes depend on things outside an OPO's hands. In a September 2026 letter supporting the recertification of LifeCenter Northwest, a bipartisan group of lawmakers asked HHS and CMS to consider circumstances beyond the OPO's control, including:

  • Whether and how transplant centers accept organs, especially medically complex ones.
  • Geography, including large, rural service areas.
  • Transportation and logistics across long distances.
  • The availability and proximity of transplant centers.

From the bedside, I'd add donor complexity and donor hospital resources to that list.

That leads to the central policy question: how do you hold OPOs accountable for what they can control without punishing them for what they can't? The plan doesn't answer it, but it is the question every reform will have to face.

8. Already Happening vs. Only Proposed

Already happening Proposed or under consideration
OPO performance standards (finalized by CMS in 2020) Fast-tracked certification process for new OPOs
First OPO decertification (announced September 2025) Organ Donation Corruption and Safety Task Force
Network for Hope decertification process (began August 2026, under appeal) More oversight of acquisition cost billing and non-profit obligations
OPTN Modernization (launched 2023) Updated HHS enforcement authority for OPTN rule violations
HOLD Act changes to the Living Organ Donor Reimbursement Program (implemented by HRSA in 2026) Expanded reimbursement eligibility for living kidney donors and a living donation awareness campaign
Patient Safety Officer requirements Stronger monitoring of that requirement and direct patient safety oversight

If you remember one thing, make it this table. A strategic plan is not a new law.

9. What Could This Mean for OPCs?

Over time, frontline coordinators could see changes in:

  • Documentation and safety: more formal reporting, auditing, and review of donor cases.
  • OPO structure: mergers, DSA changes, or new organizations entering stable markets.
  • Metrics: closer attention to authorization, conversion, utilization, and transplant.
  • Donor management: more standardization and scrutiny of clinical practice.
  • Training: higher expectations for competency and following policy.
  • Hospital relationships: trust with donor hospitals matters even more during any transition.

Bottom line for your next shift: Nothing in the Kidney Care National Plan changes OPC practice today. Keep following your OPO's policies, OPTN policy, and federal requirements as they stand now.

If you're newer to the role, this is a great time to get rock solid on the fundamentals: documentation, donor management, and the why behind each policy. That's exactly what I built the OPC Starter Pack to help with.

10. Why Public Trust Matters

Donation runs on trust: from donors, families, hospitals, candidates, clinicians, and the public. HHS explicitly ties its safety and accountability proposals to restoring that trust.

Here's how I see it. Credible oversight isn't only about catching problems. It also protects the good OPOs, and the good coordinators, by showing the public that unsafe practice won't be tolerated. When families trust the system, they say yes.

11. What to Watch Next

A strategic plan doesn't change regulations on its own. Keep an eye on:

  • CMS proposed or final rules on OPOs.
  • New HRSA guidance.
  • Any actual change to OPO certification.
  • A task force announcement.
  • Congressional action.
  • The outcome of the Network for Hope appeal and any DSA competition.
  • Changes to Medicare organ acquisition reimbursement.
  • OPTN Modernization updates.

I'll update this post as things move.

12. Final Thoughts

For years, OPO reform was mostly a debate about performance metrics. That conversation is getting much bigger. Federal policymakers are now looking at who can run an OPO, how OPOs are financed, how safety concerns get investigated, and what happens when an OPO falls short.

For us, the job is to separate today's requirements from tomorrow's proposals, and to stay ready for where the system seems to be heading. The OPO of the future may be more competitive, more transparent, and more closely watched than the one many of us walked into. Strong fundamentals and good documentation will serve you well either way.

Sources

Disclaimer: CPTCexam.com is an independent educational resource. This post summarizes publicly available federal documents for educational purposes and is not legal, regulatory, or compliance advice. It is not affiliated with or endorsed by HHS, CMS, HRSA, the OPTN, or the American Board for Transplant Certification. Always follow your OPO's policies and current federal requirements.

Back to blog